The PALB2 mutations (509_510delGA) were present in one (0.1%) of 810 cases with kidney cancer and in seven (0.15%) of 4702 controls (OR = 0.8; 95% CI, 0.10–6.75; p = 0.86). The gene discussed is PALB2; the disease is kidney cancer.